Novel Therapeutic Approach for Inhibition of HIV-1 Using Cell-Penetrating Peptide and Bacterial Toxins.

about

Novel Therapeutic Approach for Inhibition of HIV-1 Using Cell-Penetrating Peptide and Bacterial Toxins.

Item

http://www.wikidata.org/entity/Q47144668

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@en

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@nl

type

Item

label

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@en

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@nl

prefLabel

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@en

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@nl

P1476

Novel Therapeutic Approach for ...... Peptide and Bacterial Toxins.

@en

P2093

Gregory C Bernard

http://www.w3.org/2001/XMLSchema#string

Jessie Jaynes

http://www.w3.org/2001/XMLSchema#string

Marceline Egnin

http://www.w3.org/2001/XMLSchema#string

Steven Samuels

http://www.w3.org/2001/XMLSchema#string

Terry D Connell

http://www.w3.org/2001/XMLSchema#string

Toufic Nashar

http://www.w3.org/2001/XMLSchema#string

Zainab Alwan

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a major co-receptor for primary isolates of HIV-1

Virus maturation as a new HIV-1 therapeutic target

Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research

Approaches to preventative and therapeutic HIV vaccines

Antiviral mechanisms of human defensins

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

Antibody neutralization and escape by HIV-1

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

P31

scholarly article

P356

10.4172/2155-6113.1000737

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29226013

http://www.w3.org/2001/XMLSchema#string

P932

5719890

http://www.w3.org/2001/XMLSchema#string